The Intersection of Digital Health and Artificial Intelligence Quality HTA is pleased to announce the article "The Intersection of Digital Health and Artificial Intelligence: Clearing the Cloud of Uncertainty", written by Pooyeh Grail and Bijan Farhoudi has been published by Digital Health Journal now. This study discusses the concepts of Digital Health and Artificial Intelligence [...]
Integration of RWE in HTA - Quality HTA is pleased to announce the article "Integration of Real-world Evidence from Different Data Sources in Health Technology Assessment", written by Pooyeh Grail, Jason R. Guertin, Kelvin K.W. Chan, and Mina Tadrous, published by the Frontier Journal of Pharmacy & Pharmaceutical Sciences is available now. This study aimed [...]
Digital Health & Health Technology Assessment - Quality HTA is honoured to present "Digital Health and Health Technology Assessment" by Pooyeh Graili, the Founder and Principal at Quality HTA. This one-hour talk will be held at IEEE , "the world's largest technical professional organization dedicated to advancing technology for the benefit of humanity", Toronto section [...]
Conditional Funding Recommendations - Quality HTA is pleased to announce its recent paper "Conditional Funding Recommendations for Drugs in Canada: A Cross-Sectional Analysis" written by Pooyeh Grail and published online by Applied Health Economics and Health Policy is available now. This study aimed to review the conditional reimbursement recommendations issued by CADTH and explore the [...]
The Canadian Trends in Drug Purchase - The drug purchase in 2021 was 8.3% (around $35.4 billion) higher than in 2020! Dr. Mina Tadrous et. al. estimated pharmaceutical drug purchases across Canada using IQVIA data stratified by sector (retail and hospital) and forecasted annual spending to 2023. They conducted a time series analysis to calculate [...]
Quality HTA at the EU ISPOR 2022 - Quality HTA is pleased to announce the presentation of “Conditional Recommendations by the Canadian Agency for Drugs and Technologies in Health (CADTH)” at the ISPOR Conference 2022. This poster will be presented virtually by Pooyeh Graili on Monday, November 7, from 10:30 to 13:15 CET / 4:30 - [...]
CAPT-ACTP Conference 2022 - Quality HTA is pleased to announce the presentation of "Change and Trends in Conditional Recommendations; Analysis of CADTH Reports" at CAPT Conference 2022. This poster will be presented on Monday afternoon, October 17 at MaRS Discovery District, Toronto. The conference information is available here!
The CADTH Post-Market Drug Program - CADTH has launched its Post-Market Evaluation Program to address the uncertainties around the appropriate use of drugs, their long-term safety, and effectiveness after use in the real world. The cornerstone of this program, CoLab, is an evidence-generation network to support senior-level decision-makers. This network is comprised of experts in [...]
Where are we in RWE? - The best relevant RWD source needs to be decided depending on the research question. However, we still need some standard RWE frameworks, particularly when it comes to the data from Digital Health technologies considering their significant role in generating RWD. Concato J et al. have shared some interesting points [...]
Artificial Intelligence (AI) in Health Technology Assessment (HTA) - An hour presentation, AI in HTA, including the Q&A session, presented by Pooyeh Graili at ValleyML virtual meeting on October 12, 2021, is now publicly available on Vimeo. This presentation aimed to provide some insights into what HTA is and its components, who its audiences are, [...]